Personalis to Participate at the Cowen 40th Annual Health Care Conference

MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate at the upcoming Cowen 40th Annual Health Care Conference.

John West, Chief Executive Officer, will be presenting on Wednesday, March 4, 2020 at 8:40 a.m. Eastern Time at the Boston Marriott Copley Place hotel in Boston.

About Personalis, Inc.

Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. Personalis also provides genomic information to the VA Million Veterans Program as part of their goal to sequence over a million veteran genomes. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).

View source version on businesswire.com: https://www.businesswire.com/news/home/20200218005189/en/

Investor Relations Contact:
Caroline Corner
[email protected]
415-202-5678

Media Contact:
Jennifer Havlek
[email protected]
www.personalis.com
650-752-1300

Source: Personalis, Inc.

You May Also Be Interested In

• Fortune Again Recognizes Cemex as a Company That Is Changing the World
• Best Crypto Presale to Buy in 2026 as Bitcoin FOMO Hits a Two Year Peak and Pepeto Exchange Goes Live
• Dogecoin Price Prediction: DOGE Breaks Out 12% While Remittix Targets the PayFi Move Meme Coins Cannot Match